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Abstract
Background/Aims: Expression of the transcriptional co-regulator tis7 is markedly increased 
in the adaptive small intestine in a mouse model of short bowel syndrome. Transgenic mice 
with enterocytic overexpression of tis7 (tis7tg) have accelerated triglyceride absorption, with 
increased adiposity yet reduced skeletal muscle mass. To further explore this phenotype, we 
examined whether tis7 also regulates amino acid and carbohydrate absorption. Methods: 
Small intestinal glucose and amino acid uptake were quantified in wild type (WT) and tis7tg 
mice. Amino acid transporter expression was assessed by qRT-PCR and immunoblot. Apical 
cell surface transporter expression was quantified by cell surface biotinylation. Results: Active 
glucose uptake rates were unchanged. Uptake of proline but not leucine was significantly 
reduced in tis7tg vs. WT jejunum. Expression of serum and glucocorticoid-induced kinase 1 
(SGK1), a solute carrier activator, was inhibited in tis7tg jejunum. Apical membrane expression 
of the proline transporter SLC6A20 was reduced in tis7tg jejunum. Conclusions: Tis7 
overexpression in enterocytes inhibits proline uptake, associated with decreased expression of 
activated SGK1 and reduced cell surface expression of SLC6A20. Consistent with the observed 
tis7tg phenotype, tis7 overexpression increases triglyceride absorption but has adverse effects 
on the uptake of selected amino acids. Tis7 has pleiotropic effects on nutrient absorption.
IntroductionLoss of small bowel following surgical resection for treatment of disorders including Crohn’s disease, intestinal ischemia, trauma or necrotizing enterocolitis may result in short bowel syndrome. Patients with short bowel syndrome may become dependent on parenteral nutrition, with its attendant morbidity, mortality and high health care costs [1-5]. Following resection, the remnant intestine has an innate, albeit limited ability to adapt morphologically 
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and functionally following resection. This response is characterized by enhanced crypt cell proliferation, crypt depth and villus height [1-4]. There are few therapies that enhance small bowel surface area and function following resection [1-4]. The mechanistic basis of this adaptive response is being investigated in order to facilitate the discovery of novel therapeutic targets. Complicating these studies in humans is the recognition that there is remarkable heterogeneity in the adaptive response among patients [6].We have previously shown that expression of the immediate early gene tis7 (12-O-tetradecanoylphorbol-13-acetate-induced sequence 7) is markedly increased in enterocytes during the adaptive response to massive small bowel resection in a mouse model of short bowel syndrome [7, 8]. Tis7 is a transcriptional co-regulator [9] that binds to DNA binding proteins and the Sin3 complex to modulate HDAC activity [10]. Tis7 is the mouse homologue, pheochromocytoma cell-4 (PC4) the rat homologue and interferon-related developmental regulator 1 (IFRD1) the human homologue. Tis7/IFRD1 has been implicated in the regulation of cell proliferation, differentiation, and cellular responses to stress and tissue damage [9]. To further elucidate its role in gut adaptation we generated transgenic mice with intestinal enterocytic overexpression of tis7 (tis7tg) [11]. These mice have a phenotype that mimics some of the metabolic changes found in parenteral nutrition dependent patients with short bowel syndrome. For example, tis7tg mice have increased body fat yet reduced skeletal muscle mass, similar to what has been observed in these patients [11]. These mice also exhibit accelerated triglyceride absorption, and more rapid and proportionately greater weight gain on a high fat diet [11]. However, when fed a chow (low fat) diet, tis7tg mice have significantly lower body weight compared to WT littermates, despite consuming the same amount of chow [11]. These observations suggested that intestinal absorption of other nutrients in addition to lipids is altered in tis7tg mice. Since tis7 functions as a transcriptional co-regulator [9], this might occur by regulating the expression of a wide range of genes involved in the digestion [12, 13] and uptake [14] of dietary proteins and carbohydrates. In the present study, we addressed the hypothesis that tis7 regulates protein and/or carbohydrate absorption, by investigating glucose and amino acid uptake in 
tis7tg compared to WT intestine, using in vitro everted sleeve techniques [15].Glucose uptake is primarily mediated by the sodium-glucose co-transporter 1 (SGLT1) 
and to a lesser extent, by the glucose transporter 2 (GLUT2) [16]. We chose to first study the uptake and absorption of neutral amino acids including L-proline and leucine [17], because mice that are null for the neutral amino acid cotransporter Slc6A19 have a similar phenotype to the tis7tg mouse, with significantly lower body weight compared to WTs when fed a chow diet [18]. Our data showed that proline uptake into tis7tg intestine was significantly reduced compared to WT intestine, whereas glucose and leucine uptake was unchanged. Reduced proline absorption was associated with decreased apical cell surface expression of SLC6A20, and decreased expression of the activated (phosphorylated) form of serum and glucocorticoid-induced kinase 1 (pSGK1), a known activator of a subset of ion channels and solute carriers [19]. Our data suggest that tis7 plays a novel role in the regulation of intestinal nutrient uptake. Increased enterocytic tis7 expression results in increased triglyceride absorption but has adverse effects on the uptake of selected amino acids.
Materials and Methods
Materials
Sources: The anesthetic isoflurane was from Butler Schein Animal Health (Dublin, OH). Radiolabeled probes D-[14C(U)] glucose (D-glc), L-[14C(U)] proline (L-pro), L-[14C(U)] leucine (L-leu) and radiolabeled markers L-[1-3H] glucose, [1,2-3H] PEG 4000, were from American Radiolabeled Chemicals, Inc (St Louis, MO). Tissue solubilizer and Ultima Gold liquid scintillation cocktail were from Perkin-Elmer (Waltham, MA). Oligonucleotide primers were from Integrated DNA Technologies Inc. (Coralville, IA). Pierce Cell Surface Protein Isolation Kit and 100X Halt Protease and Phosphatase Inhibitor Cocktail were from Thermo 
Fisher Scientific Inc. (Rockford, IL). TRIzol, DNA-free kit, Super-Script II reverse transcriptase and 2x Sybr 
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Green Master Mix were from Life Technologies (Carlsbad, CA). Anti-pThr256-SGK (sc16744R), anti-β-actin (sc47778), anti-SGLT1 (sc98974), anti-sucrase-isomaltase (SI) (sc27603), anti-SLC6A20 (sc134762), anti-SLC6A19 (sc160812), anti-SLC36A1 (sc368553) antibody and donkey anti-goat IgG-HRP (sc-2020) were 
from Santa Cruz Biotechnology (Dallas, TX). Anti-mouse and anti-rabbit HRP conjugate and Amersham ECL 
Western Blotting Detection Reagents (RPN2106) were from GE Healthcare Life Sciences.
AnimalsThe Washington University School of Medicine Animal Studies Committee reviewed and approved all animal experimentation. Tis7tg mice were generated as per [11] on an FVB/N background. WT FVB/N littermates were used as controls for all tis7tg experiments. All mice were bred and housed together in the same room of the Washington University School of Medicine mouse facility. The mice were fed a standard 
rodent chow diet (Picolab 20, Ralston Purina) containing by weight 20.0% protein, 5.6% fat, 4.7% fiber, 52.9% carbohydrate, 6.1% minerals, 0.7% vitamins and 10% water, and were kept on a strict 12hr:12hr light dark cycle. Protein, fat and carbohydrate accounted for 24.7%, 13.2% and 62.1 % of calories, respectively.
Intestinal resection surgery The protocols for intestinal resection surgery and for the provision of a liquid high fat diet (42% kcals 
from fat, Modified, High Fat AIN-93M purified liquid diet 710147, Dyets Inc, Bethlehem PA) for 3 weeks 
post-op were as described [7]. Briefly, two days prior to surgery mice were acclimated to a liquid control diet nutritionally equivalent to standard rodent chow (described below). On the day of surgery mice were 
anesthetized with ketamine (87 mg/kg) xylazine HCL (13 mg/kg) and isoflurane inhalation. A 50% small bowel resection was performed starting 3 cm from the ligament of Treitz and ending 8 cm from the ileocecal 
junction [20]. A primary end-to-end anastomosis was made between the remaining jejunum and ileum and the abdominal cavity was closed in two layers. For control sham surgeries a single incision was made 9 cm 
from the ileocecal junction, and the intestine was re-sutured at this site and the abdominal cavity closed as above. Mice received 0.2 mg gentamicin in 0.5 ml saline, 0.03 mg/kg buprenorphine I.P. for analgesia, and 
2.5cc 0.9% sodium chloride I.P. for fluid resuscitation. Mice recovered in an Air Shields isolette incubator at 31°C overnight, and were sacrificed on day 21 post-resection. Remnant duodenum-jejunal, ileal and 
anastomotic segments were harvested and frozen in liquid nitrogen or fixed in formalin. Mice that had poor 
p.o. intake, excessive weight loss, or were otherwise distressed based on daily monitoring were sacrificed and excluded from further analyses.
High fat diet feeding post surgeryThe high fat liquid diet was prepared by liquefying 225.0 g of diet powder in 1 L water in a food processor for 30 sec, containing 38.7 g/L protein (casein, 100 mesh), 0.5 g/L L-cystine, 35.6 g/L milk fat, 11.1 g/L soybean oil, 27.7 g/L sucrose, 81.5 g/L maltose dextrin, 3 g/L xanthan gum, 13.8 g/L cellulose 
(fiber), 9.7 g/L minerals and 2.77 g/L vitamins. Protein, fat and carbohydrate accounted for 140.5, 420.3 and 420.5 kcal per liter of liquid diet, respectively. Mice were fed the high fat diet for 21 days postop. Calorie intake and weights were monitored q1- 2days.
In vitro intestinal glucose, proline and leucine uptake measurements 
In vitro intestinal glucose (glc), proline (pro) and leucine (leu) uptake were measured using a modified everted sleeve technique [15, 21]. Intestines from 3-month old tis7tg mice and WT littermates were used for glucose and proline uptake experiments (n = 5 tis7tg, n = 6 WT), and for leucine uptake and cell-surface biotinylation experiments (n = 6 tis7tg, n = 6 WT). To minimize the effect of diurnal variation in expression 
and function of hexose transporters, one mouse per day was sacrificed between 9:30 AM to 10:00 AM. The small intestine was rapidly removed, placed on a cold chop board and divided into three segments: the 
proximal 10 cm, the middle 16-20 cm and the distal 9 cm, designated as duodenum, jejunum and ileum. The proximal 4 cm of duodenum and the distal 3 cm of ileum were snap frozen in liquid nitrogen for RNA isolation; the middle 4 cm of duodenum and ileum were cut in half as duplicates for glucose or leucine 
uptake determinations; the middle 4 cm of jejunum was cut in half for proline or leucine uptake and the 
adjacent 4 cm was saved for cell-surface biotinylation. After the luminal contents were gently removed, a 2-cm intestinal segment was tied with 5-0 nylon suture (Surgical Specialties Corp., Reading, PA) at one 
end, which served as an anchor on the flat end of a stainless steel round rod (1.57 x 300 mm). The rod was advanced into the intestinal lumen and the segment everted on the rod. A 1.0 cm everted sleeve was 
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secured on the rod with two 5-0 suture ties and extra tissue removed from both edges. The sleeves were maintained in chilled (4°C) mammalian Ringers solution (128 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM MgSO4, 20 mM NaHCO3, pH 7.3-7.4) bubbled with 95% O2/5% CO2 until ready for the uptake 
measurement. About 75 min after sacrifice, everted sleeves were inserted in 3-hole cork stoppers in pairs 
and sequentially placed in a flat bottom round tube (25 x 150 mm) in a 38°C bath and pre-incubated in 8 ml of mammalian Ringers solution bubbled with 95% O2/5% CO2 for 5 min. Each pair of everted sleeves 
was then transferred to another flat bottom round tube in a 38°C bath and incubated in 8 ml of mammalian Ringers solution with iso-osmotic replacement of NaCl using 20 mM non-radiolabeled D-Glc, L-Pro or L-Leu 
and containing 1 μCi of each probe D-[14C(U)] glucose (D-glc), L-[14C(U)] proline (L-pro), L-[14C(U)] leucine 
(L-leu) and and 2 μCi of marker (radiolabeled markers L-[1-3H] glucose and [1,2-3H] PEG 4000 for proline and leucine uptake experiments). The solution was stirred at 1,200 rpm to mix the unstirred layer. After 1 min incubation, the tissues were removed, rinsed quickly in 25 ml of chilled mammalian Ringers solution stirred at 1,200 rpm for 20 s, and placed in glass scintillation vials. Tissue solubilizer was added to the vials and incubated at 37°C overnight. After complete solubilization, 5 ml of Ultima Gold cocktail was added and 
radioactivity measured in a Beckman LS 3801 scintillation counter. The probe uptake rate J is defined as J = (P – R·M)/(H·t·m), where P and M represent the DPM of the probe and marker in the tissue, respectively, R is the ratio of the probe radioactivity over the marker radioactivity in the incubation solution, H is the ratio of the probe radioactivity to the total amount of radiolabeled and non-radiolabeled probe in nmol, t is the incubation time and m is the length of intestine. [1,2-3H] PEG 4000 was used as a marker in the pro and leu 
uptake experiments to measure adherent fluid and L-[1-3H] glucose was used in the glc uptake experiment to measure adherent glucose and passive uptake. Thus, the resulting rates measured were total uptake rates for pro and leu, and active transporter-mediated uptake rate for glc, respectively.
Intestinal gene expression analysis by qRT-PCRTotal RNA from duodenum and ileum was extracted by TRIzol and treated with DNase I using the DNA-free kit. First strand cDNA was synthesized from 1.5 µg of total RNA using Super-Script II reverse transcriptase with random hexamer primers. Real time PCR analysis was performed on an StepOnePlus 
Real-Time PCR system (Applied Biosystems, Foster City, CA) using 2x Sybr Green Master Mix. Primers used in quantitative RT-PCR are as follows: Slc38a2: forward, 5’- GGC TAT GTC AAG CTA CCT CTTC-3’; and reverse, 5’- GTC ACC GTT CAG ATA CCA CAA-3’; Slc6a196A19: forward, 5’- TGT CAA CAC GAA CAT CCT GAC CCT-3’; and reverse, 5’- TTA GTG GCA TTG CAC CAC TGT TGG-3’; SLC6A14: forward, 5’- CCT CTG GCA AGG TGG TAT ATTT-3’; and reverse, 5’- TCC AAA GTT GCA CCT CGT ATTA-3’; Slc6a20a: forward, 5’- GAT GTA CGG CGG AGG GAG TTTC-3’; and reverse, 5’- AGA CCA CAA CAC TGG CAA CAC; SLC36A1: forward, 5’- CAT CGT GGA CTT CTT CCT CATC-3’; reverse, 5’- CTG CCT CTA TCA CCT GCT TAAA-3’; Ace2: forward, 5’- CCC AAA GAG CAG TGG ATGAA-3’; reverse, 5’- GAG ATG CAG GGT CAC AGT ATG-3’; Sgk1K1: forward, 5’- GGC TAT CTG CAC TCC CTA AAC-3’; reverse, 5’- AAA GTC AGT GAG GAC GAT GTG-3’; GAPDH, 5’- TGT GTC CGT CGT GGA TCT GA-3’; 
reverse, 5’- CCT GCT TCA CCA CCT TCT TGA-3’. The relative mRNA level was defined as 2-∆Cт, where ∆C
т
 = C
т
 gene of interest – C
т
 internal control [22], and the internal control was GAPDH.
Intestinal apical cell-surface biotinylationIntestinal apical cell surface biotinylation was carried out using Pierce Cell Surface Protein Isolation 
Kit per manufacturer’s instructions modified as per [23-25]. Briefly, a 4-cm jejunal segment from the leu 
uptake experiment was flushed with cold PBS-CM (PBS with 0.1mM CaCl2, 1.0mM MgCl2, pH 7.2). Both ends of the segment were closed with 5-0 nylon sutures, placed on a cold chop board, and 0.3 mL of fresh 
1.0 mg/mL sulfo-NHS-SS-biotin in ice-cold PBS-CM was injected into the lumen and incubated at 4°C for 
30 min. Both ends of the loops were removed and the lumen was flushed twice with 2.5 mL of ice-cold 
PBS/100 mM glycine buffer to quench the free biotin, and then twice with 2.5 mL of ice-cold TBS. The loop was cut longitudinally along the opposite side of the mesentery to expose the luminal surface. Mucosa was scraped with a microscope slide and suspended in 1.0 mL of cold TGH lysis buffer containing 1% (v/v) Triton X-100, 10% (v/v) Glycerol, 25 mM HEPES (pH 7.4) and 5 mM EDTA. 10 µL of the 100x Halt Protease and Phosphatase Inhibitor Cocktail was added and the mucosa was homogenized with a Polytron PT 10/35 
tissue homogenizer (Brinkmann Instruments, Westbury, NY) at 23,000 rpm for 7 sec, and then incubated on ice for 30 min with occasional brief vortexing. The mucosal lysate was centrifuged at 10,000x g for 2 min at 4°C. The supernatant and pellet were stored at -20 °C without separation. The protein concentration 
was determined by the CB-X protein assay (G-Biosciences, St. Louis, MO). NeutrAvidin Agarose slurry (500 
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μL) in a column was washed with 3x 500μL of Wash Buffer. The clarified cell lysate containing 1.0 mg of total soluble proteins was added to the column, which was placed on a rotary mixer and incubated at room temperature (RT) for 60 min. The column was then centrifuged for 1 min at 1000x g and flow-through 
discarded. The column was washed four times with 500 μL of Wash Buffer containing 5 µL of 100x inhibitor 
cocktail, and then 400 μL of the Sample Buffer (2.5 parts of 4x NuPAGE LDS sample buffer, 1 part of 0.5 M DDT and 6.5 parts of water) was added to release the bound biotinylated proteins. The column was then placed on a rotary mixer and incubated at RT for 60 min. Column was centrifuged for 2 min at 1000 × g and the eluate stored at -20°C for immunoblotting.
Intestinal epithelial protein expression analysis by immunoblotIntestinal epithelial protein expression by immunoblot was carried out using the XCell SureLock Mini-
Cell for electrophoresis and iBlot 7-minute blotting system for protein transfer (Life Technologies, Carlsbad, CA). Samples were prepared according to manufacturer’s instruction and 15 µg of total soluble proteins or 6.5 µg of cell-surface biotinylated proteins were loaded onto a NuPAGE Novex 10% Bis-Tris Gel (1.0 mm, 10 Well). A sample containing 15 µg of total soluble proteins from a full-thickness jejunum segment of a 
C57BL/6 WT mouse was loaded on each gel as an inter-gel normalization standard. Protein ladders were 
transferred to a nitrocellulose membrane. After blocking with 5 % non-fat dry milk in TBS/0.1 % Tween 20 at RT 1h, the blot was incubated at 4°C overnight with the primary antibody, followed by incubation 
with a horseradish-conjugated secondary antibody at RT for 1 h, and visualized by Amersham ECL Western 
Blotting Detection Reagents on autoradiography film (Molecular Technologies, St Louis, MO). Anti-pThr256-SGK, anti-β-actin, anti-SGLT1, anti-SI, anti-SLC6A20, anti-SLC6A19 antibodies were sequentially employed in western blotting of total soluble proteins, whereas anti-SGLT1, anti-SI, anti-SLC6A20, anti-SLC6A19, anti-SLC36A1 and anti-β-actin were sequentially employed in immunoblotting of cell-surface biotinylated 
proteins. All primary antibodies were used in 1:200 dilutions in TBS/0.1% Tween 20/5% non-fat dry milk. 
All secondary antibodies were used in 1:10,000 dilutions in TBS/0.1% Tween 20/5% non-fat dry milk except for anti-SLC36A1 antibody detection, which was diluted 1:2000. The mild stripping procedure used at the end of each round of immunoblotting entailed incubation twice for 10 min in stripping buffer (106.6 
mM glycine, 0.1% SDS, 1% Tween 20, pH 2.2), followed by incubation twice in PBS and then by washing 
twice for 5 min in TBS/0.1% Tween 20. Protein bands on the immunoblot were quantified using ImageJ 
software (http://rsb.info.nih.gov/ij/index.html). The measured density of the experimental sample was normalized to the standard sample, and then normalized to the loading controls β-actin and SGLT1 for the analyses of total soluble proteins and cell-surface biotinylated proteins.
Statistical analysisUnpaired Student’s t-tests were performed for analysis of data from tis7tg vs. WT littermate mice; a p 
value ≤ 0.05 was considered statistically significant.
Results
Glucose uptake is unaltered by enterocytic tis7 overexpressionActive transporter-mediated glucose uptake rates in everted sleeves were similar to previously reported (normal) rates [15] and there was no difference in average active glucose uptake rates in WT compared to tis7tg transgenic duodenum (85 nmol min-1 cm-1 vs. 106 nmol min-1 cm-1 respectively (p = NS, Fig. 1A); Glucose uptake rates were also unchanged in tis7tg compared to WT ileum (Fig. 1A). As expected, glucose uptake rates were significantly lower in both WT and tis7tg ileum compared to WT and tis7tg duodenum respectively, consistent with the known regional patterns of SGLT1 expression [21]. Thus enterocytic tis7 overexpression did not affect glucose uptake.
Reduced small intestinal proline uptake in tis7tg jejunum
Because the neutral amino acid cotransporter Slc6a19 null mouse has a similar phenotype to the tis7tg mouse, with significantly lower body weight compared to WT littermates when fed a chow diet [18], we examined the uptake of neutral amino acids 
including L-proline and leucine [15]. As shown in Fig. 1B, the average proline uptake rate 
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in WT jejunum was 165 nmol min-1 cm-1. In contrast, the average proline uptake rate in 
tis7tg jejunum was significantly reduced to 77 nmol min-1 cm-1 (p < 0.01).To determine whether the reduction in amino acid uptake was unique to proline or if transport of other neutral amino acids was affected by tis7 overexpression, we measured leucine uptake rates. Average leucine uptake 
in WT jejunum was 116 nmol min-1 cm-1 (Fig. 1C) and the average tis7tg jejunal leucine uptake rate was 92 nmol min-1 cm-1, which 
was not significantly different from WT. To determine whether regional variation in leucine uptake along the horizontal axis of the intestine might mask differences between WT and TG, we measured uptake in 
Fig. 1. Reduced proline transport in Tis7tg vs. WT small intestine. Uptake rates of D-glucose (A), proline (B) and leucine (C) were measured in vitro by the everted sleeve technique. (A) Glucose uptake rates are higher 
in duodenum compared to ileum but there is no significant difference comparing tis7tg to WT. WT duodenum 
vs. WT ileum ; + p ≤ 0.05 ; Tis7tg duodenum vs. tis7tg ileum ** p≤ 0.05. (B) Proline uptake is reduced in tis7tg 
vs WT jejunum; ++p ≤ 0.05. (C). Leucine uptake is unchanged in tis7tg vs WT jejunum. Error bars represent the SEM.
Fig. 2. Leucine uptake is unchanged in tis7tg vs. WT 
duodenum, jejunum and ileum. Leucine uptake was measured as per Methods. Leucine uptake rates in 
duodenum and jejunum are higher than  in ileum but 
there were no significant differences comparing WT vs. tis7tg leucine uptake.
the duodenum and ileum (Fig. 2). Leucine uptake rates were highest in WT jejunum (116 nmol min-1 cm-1) compared to duodenum and ileum (average rates = 99 and 44 nmol min-1 cm-1 respectively), but there were no significant differences comparing WT vs. tis7tg leucine uptake in duodenum or ileum.
Altered expression of amino acid transporters in tis7tg and WT small intestineTo begin to elucidate the molecular mechanisms regulating the observed reduction in proline uptake, we analyzed amino acid transporter expression in the tis7tg and WT duodenum and ileum by qRT-PCR. The amino acid transporters that transport neutral amino 
acids including proline in the gut are SLC38A2 (SNAT2), SLC6A19 (B0AT1), SLC6A14, and 
SLC36A1 (PAT1) [17]. SLC6A20 (SIT1) is specific for proline/imino acids.
Of the five transporters, Slc6a20a mRNA was the most abundantly expressed among all 
transporters in the jejunum. Slc6a14 mRNA expression was lowest along the entire length of the small bowel (Fig. 3A-C). Slc6a20, Slc38a2 and Slc36a1 (Pat1) were most abundantly ex-
pressed in jejunum compared to duodenum and ileum, whereas Slc6a14 levels were highest in ileum. Slc6a19 had similar expression levels in jejunum and ileum.Comparing Tis7tg to WT there was a small (1.3-fold) but significant increase in duodenal 
Slc6a19 expression (Fig. 3A), and a significant increase in duodenal (2.3-fold) and ileal (1.2-fold) Slc36a1 expression (Fig. 3A and 3C, respectively).
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Reduced SGK1 mRNA expressi-
on in tis7tg ileumAlthough proline uptake was reduced in tis7tg vs. WT intestine, transporter expression levels were either unchanged or showed a small 
but significant increase in tis7tg vs WT intestine (Fig. 3). Thus we next sought to examine the expression of genes that regulate transporter ac-tivity and/or its cell surface expres-sion, which in turn might be regu-lated by tis7 overexpression, via its function as a transcriptional co-re-gulator. Angiotensin-converting en-zyme 2 (ACE2) is a cell-surface ex-pression partner of SLC6A19 [26]. We observed regional differences in Ace2 expression levels along the length of the small bowel, with a si-
gnificant increase in ileal compared to duodenal Ace2 expression in both WT and tis7tg mice (3.2-fold and 2.3-fold, respectively, *p < 0.0001 for both, Fig. 4A). However, intestinal tis7 overexpression did not affect 
Ace2 mRNA levels as there was no 
significant difference in Ace2 ex-pression in WT vs Tis7tg duodenum or ileum (Fig. 4A).SGK1, 2 and 3 play important roles in regulating amino acid transporter activity [27]. PI3 
Fig. 3. Amino acid transporter mRNA expression in WT and 
tis7tg small intestine. Relative mRNA expression in (A) duode-
num (B) jejunum, and (C) ileum was measured by qRT-PCR. (A). WT vs tis7tg duodenum, # p ≤ 0.05. (C). WT vs tis7tg ileum, 
* p ≤ 0.05. Error bars represent the SEM.
kinase activates SGKs which then stimulate intestinal glucose and amino acid transporters; global inhibition of PI3 kinase inhibits amino acid and glucose transport via inhibition of SGK activation. SGK1 has also been shown to enhance cell-surface expression of SLC6A19 in Xenopus oocytes [25]. Since SGK1 has five isoforms (SGK1a-e) [28-30], a primer pair from the conserved region of these isoforms was chosen so that the total mRNA level was measured by qRT-PCR.
We observed significant regional differences in Sgk1 expression, with increased Sgk1 
expression in ileum compared to duodenum and in jejunum compared to duodenum in both WT and tis7tg mice (3.0-fold higher in WT ileum vs. duodenum (p < 0.0001), 2.3-fold higher in tis7tg ileum vs. duodenum (p < 0.008), 2.6 fold higher in WT jejunum vs. duodenum (p < 0.002) and 1.9 fold higher in tis7tg jejunum vs. duodenum (p < 0.019; Fig. 4B)). We also 
observed significantly decreased Sgk1 mRNA levels in tis7tg compared to WT jejunum (2.1-fold, p < 0.013) and ileum (2.1-fold, p < 0.002, Fig. 4B). Sgk2 mRNA levels were also lower in 
tis7tg vs. WT duodenum (1.3-fold, p<0.005) but not in other intestinal segments. Sgk3 mRNA levels were unchanged.
Reduced activated SGK1 expression (pSGK1) in tis7tg jejunumProline transporter cell surface expression is regulated by activated SGK1, thus we hypothesized that decreased activated SGK1 expression might in turn reduce transporter cell surface expression. Therefore we examined the expression of activated SGK1 (pSGK1) which is phosphorylated at residues Thr349 and Ser515, by immunoblot analysis (Fig. 5A). 
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All five phosphorylated SGK isoforms1a-e and phosphorylated SGK2 were detected on the immunoblot, including pSGK1a (59.7 kDa), pSGK1b (46.1 kDa) , pSGK1c (47.7 kDa), pSGK1d (50.7 kDa) and pSGK1e (49.1 kDa). 
Quantification of pSGK1 expression was based on the total phosphorylated protein rather than individual isoforms. Activated SGK1 expression was 2.7 fold higher in the WT mouse compared to Tis7tg mouse 
(Fig. 5B). pSGK2 expression in the tis7tg intestine also trended lower than WT (p = 0.1).
Reduced intestinal apical membrane 
expression of the proline-specific 
transporter SLC6A20 in tis7tg miceTo determine whether decreased pSGK1 was associated with decreased amino acid transporter cell-surface expression [25], 
jejunal total cellular (Fig. 6A) as well as api 
cal membrane expression (Fig. 6B) of the neutral amino acid transporter SLC6A19 and 
the proline-specific transporters SLC6A20 and SLC36A1 were examined by immunob-lot. Apical membrane expression was mea-sured by surface biotinylation. The glucose transporter SGLT1 and the intestinal absorp-tive cell surface membrane protein sucrose- isomaltase (SI) were included as controls.Densitometric analysis revealed that the 
total cellular expression levels of these five 
Fig. 4. SGK1 but not ACE2 mRNA expression is re-duced in tis7tg vs. WT jejunum (JEJ) and ileum (DIL). Relative mRNA expression of the transporter co-re-
gulators ACE2 (A) and SGK1 (B) was measured by 
qRT-PCR. (A). WT duodenum (DD) vs. WT JEJ, * p ≤ 0.05; tis7tg DD vs. tis7tg JEJ, + p ≤ 0.05; WT DD vs WT 
DIL, ++p ≤ 0.05; tis7tg DD vs. tis7tg DIL, ** p ≤ 0.05. B. 
WT DD vs. WT JEJ, * p ≤ 0.05; tis7tg DD vs. tis7tg JEJ, + 
p ≤ 0.05; WT JEJ vs. Tis7tg JEJ, +++ p ≤ 0.05. WT DIL vs. 
Tis7tg DIL, *** p ≤ 0.05.proteins were not different in WT and tis7tg jejunum (Fig. 6C). Evaluation of apical membrane expression by cell surface biotinylation revealed that all 5 proteins were readily detected in the apical membrane-bound fraction. To control for variability in cell-surface biotinylation, 
SGLT1 was used as a loading control. We observed a small (13%) but significant decrease in 
Tis7tg compared to WT jejunal apical membrane expression of the Pro-specific transporter SLC6A20 (Fig. 6D, p < 0.048). Cell surface expression of SLC6A19 and SLC36A1 were unchanged.
Body weight gain is unchanged in high fat fed tis7tg mice post resectionWeight gain and maintenance of adequate oral nutrition after massive small bowel 
resection is a major clinical problem for patients with short bowel syndrome. Tis7tg mice were previously shown to have accelerated triglyceride absorption and exhibit a phenotype that mimics some of the metabolic changes found in parenteral nutrition dependent patients with short bowel syndrome [11]. We therefore employed a mouse model of short bowel syndrome, to determine whether intestinal tis7 overexpression could increase weight gain post resection. We performed 50% small bowel resections and fed a high saturated fat diet to tis7tg and WT mice for 21 days post resection, Daily weights were measured. We observed that body weight recovery was the same in tis7tg and WT mice throughout the entire 21 day post op period (Fig. 7).
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Fig. 5. Reduced expression of phosphorylated SGK1 (pSGK1) in tis7tg vs. WT jejunum. (A) Immunoblot sho-
wing the expression of activated (phosphorylated) SGK1 isoforms a-e (pSGK1a-e) and pSGK2 in jejunal mu-
cosa. The first 4 lanes from left are WT, the next 4 lanes are tis7tg, and the right lane is the molecular weight standard. β-actin was measured as a loading control. (B) Protein expression was quantified as the adjusted 
density of the protein band or the sum of protein bands in case of pSGK1a-e. * p ≤ 0.05 WT vs. tis7tg JEJ; error bars represent the SEM. WT, wild type, TG, transgenic.
Fig. 6. Reduced intestinal apical membrane expression of the proline-specific transporter SLC6A20 in tis7tg mice. (A) Immunoblot analysis of total cellular expression of the intestinal brush border protein sucra-se-isomaltase (SI), and transporters for Glc (SGLT1), Pro (SLC6A20 and SLC36A1) and Leu (SLC6A19) in the 
supernatant of jejunum mucosa. (B) Expression in the apical membrane-bound fraction isolated through cell-surface biotinylation and analyzed by immunoblot. β-actin and SGLT1 served as the respective loading 
controls. Expression was quantified as the normalized densities of protein bands, as in (C) and (D), respecti-
vely. The inserted chart in (C) is a scale-adjusted quantification of SI, SGLT1, SLC6A19 and SLC6A20 protein 
expression. * p ≤ 0.05 WT vs. Tis7tg jejunum ; error bars represent the SEM.
Fig. 7. Body weight recovery is unchanged in high fat diet fed tis7tg vs. WT mice after 50% small bo-wel resection. Mice had 50% small bowel resection and were fed a high saturated fat “Western” diet for 
21 days post resection. Body weight was measured daily.
DiscussionWe have previously observed that chow-fed tis7tg mice have decreased body weight with a relative increase in adiposity (due 
D
ow
nl
oa
de
d 
by
: 
W
as
hi
ng
to
n 
Un
ive
rs
ity
   
   
   
   
   
   
   
   
   
   
   
 
12
8.
25
2.
21
4.
22
8 
- 4
/2
7/
20
17
 1
:1
7:
35
 A
M
Cell Physiol Biochem 2016;38:1532-1543
DOI: 10.1159/000443094
Published online: April 07, 2016 1541
Lu et al.: Reduced Proline Absorption in Tis7 Transgenic Mice
Cellular Physiology 
and Biochemistry
© 2016 The Author(s). Published by S. Karger AG, Basel
www.karger.com/cpb
to enhanced triglyceride absorption) yet a reduction in lean body mass compared to WT littermates [11]. Herein we have shown that tis7 overexpression in intestinal enterocytes results in reduced proline but not reduced leucine uptake, decreased expression of activated SGK1 and decreased cell surface expression of the proline/ imino acid transporter SLC6A20. Reduced intestinal proline transport may in part explain the reduction in lean body mass in 
tis7tg mice, as well as the lack of enhanced weight gain in tis7tg vs. WT mice post-resection (Fig. 7). However it is likely that additional mechanisms play a role; for example, adverse effects on the transport of other amino acids or peptides may also contribute to this phenotype. Although humans utilize the peptide transporter PepT1 to transport dipeptides and thus do 
not become protein deficient in the setting of reduced amino acid transport as in Hartnup’s disease, mice have substantial reductions in body weight and lean body mass when amino acid transport is reduced [18]. For example mice in which the neutral amino acid transporter SCL6A19 is deleted [18], have reduced body weight and lean body mass. Our studies suggest that reduced proline uptake from the diet may affect the synthesis of key muscle proteins.Expression of activated serine and threonine kinase SGK1 was markedly decreased 
in the transgenic jejunum and ileum. Activated SGK1 regulates ion channels, carriers and 
transporters, including the neutral amino acid transporter SLC6A19 (also known as B(0)AT1 [25], the glucose transporter SGLT and uniporters Glut1 and Glut4 [31]. SGK1 regulates transporter activity directly by phosphorylation, or by prevention of ubiquitination and degradation that enhances cell surface retention of carriers [19]. SGK1 has been shown to regulate SLC6A19 activity by increasing its cell surface expression via inhibition of ubiquitin ligase mediated degradation [25]. However, SGK1 appears to be required for activated 
transport, in response to factors such as glucocorticoids or inflammation, and not for basal transporter activity. Its effects on SGLT1 and SLC6A19 activity are only found in the setting of increased transporter activity induced by cellular stress or glucocorticoid excess [32]. For example, basal activities of SGLT1 and NHE3 are identical in the intestine of the SGK1 
knockout intestine compared to WT before but are significantly different after exposure to dexamethasone [32]. Our experiments were performed in non-stressed conditions without growth factors or glucocorticoid exposure. Thus, despite the reduction in activated SGK1 levels, we did not observe a reduction in cell surface expression of SLC6A19 or SGLT1. However, a modest decrease in cell surface expression of the IMINO transporter SLC6A20 was detected, suggesting that basal cell surface expression of SLC6A20 may be more dependent upon activated SGK1. SLC6A20 mutation has been implicated as a cause of iminoglycinuria [17]. However, the modest observed reduction in SLC6A20 cell surface expression does not fully explain a 50% reduction in proline transport, suggesting additional mechanisms that have yet to be explored. For example, SGK1 may also regulate proline transport directly by affecting transporter phosphorylation. Future experiments will be directed to further elucidate the underlying mechanism(s).The mechanisms by which SGK1 expression is inhibited by tis7 overexpression are unclear. SGK1 is ubiquitously expressed and its activity is induced by hormones such as glucocorticoids and cell stress [19]. SGK1 is also activated by insulin and growth factors such as the insulin-like growth factor-1 via phosphatidylinositol 3-kinase, the 3-phosphoinositide-dependent kinase [33], and mammalian target of rapamycin [31]. We previously observed that serum IGF-1 levels in tis7tg mice are significantly lower than in WT littermates [11], suggesting a potential mechanism for the reduced expression of activated SGK1 in the tis7tg intestinal mucosa compared to WT littermates. Alternatively, tis7 may inhibit SGK1 via 
its cell-type- and target gene-specific function as a transcriptional coactivator [34, 35] or corepressor [10, 36]. Future studies will address whether tis7 interacts with the SIN3 histone deacetylase complex to inhibit SGK1 expression, as it does to regulate cellular retinoic acid binding protein II expression in mammary epithelium [10].Therapies that are directed towards enhancing nutrient and calorie absorption in short bowel syndrome are lacking. In these studies we sought to determine whether tis7 overexpression might provide a nutrient absorptive advantage post resection. Despite our previous observation that mice with intestinal tis7 overexpression have increased gut 
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triglyceride absorption and accelerated weight gain when fed a high saturated fat diet, tis7tg and WT mice had similar weight gain after 50% small bowel resection (Fig. 7). It is possible that enhanced triglyceride absorption driven by tis7 overexpression in the remaining intestine could not compensate for the massive loss of absorptive function following 50% resection. Alternatively, the reduction in proline transport, which is further decreased following massive resection, may explain the lack of enhanced weight gain. Additional studies in which more limited resections are performed may help clarify these issues.In summary, tis7 regulates multiple intestinal nutrient absorptive pathways. Our previous studies showed that enterocytic tis7 overexpression resulted in increased adiposity but decreased lean body mass, similar to the metabolic phenotype of patients with short bowel syndrome who are fed with parenteral nutrition [11]. These studies provide a potential explanation for reduced lean body mass in these mice, although it is likely that tis7 overexpression affects absorption of other amino acids as well. Reduced proline absorption in the intestinal tis7tg mouse is associated with decreased apical cell surface expression of SLC6A20, which is likely mediated by reduced SGK1 expression, a key regulator of nutrient transporters and channels. The tis7tg mouse thus represents a novel model to study the metabolic pathogenesis of short bowel syndrome.
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